United StatesCetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single‑Dose Kit, Rx Only, manufactured for Meitheal Pharmaceuticals (NDC 71288-558-90), Lot Q4E0112A, Exp. 30 Apr 2027 (16,477 kits) is being recalled nationwide in the U.S. The recall was issued because the injection kit may have a defective delivery system with missing or duplicated needles.
What's being recalled
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Recalling firm: Meitheal Pharmaceuticals, Inc, Chicago, IL, United States.
How to identify it
Lot Q4E0112A, Exp.: 30 Apr 2027
The hazard
Defective Delivery System: Missing or duplicated needles within the injection kit
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)